Leadership
Elena Piskounova, PhD
Founder & CEO
Assistant Professor at Harvard Medical School with 15+ years of expertise in RNA biology and metastatic disease. Senior author of the foundational publications underlying O₂nix Bio's science, including landmark work in Nature (2015) and Nature Cancer (2024).
Doug Donzelli
Business Advisor
President & CEO and co-founder of Synfini Inc., O₂nix Bio's drug discovery partner. Brings 40+ years of executive experience across healthcare, medical devices, and chemistry.
Scientific Advisory Board
Samie Jaffrey, MD, PhD
Scientific Advisor
Professor, Weill Cornell Medicine. Expertise in RNA regulatory mechanisms and modifications.
Richard Gregory, PhD
Scientific Advisor
Professor, UMass Chan Medical School. Expertise in RNA regulation in cancer.
Wendy Gilbert, PhD
Scientific Advisor
Professor, Yale School of Medicine. Expertise in RNA regulation and modifications.
Strategic Partners
Synfini Inc. — AI-driven drug discovery partnership. Learn more